Taiwan Advanced Nanotech Inc.
Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plat… Read more
Taiwan Advanced Nanotech Inc. (6797) - Total Assets
Latest total assets as of June 2025: NT$1.34 Billion TWD
Based on the latest financial reports, Taiwan Advanced Nanotech Inc. (6797) holds total assets worth NT$1.34 Billion TWD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Taiwan Advanced Nanotech Inc. - Total Assets Trend (2019–2024)
This chart illustrates how Taiwan Advanced Nanotech Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Taiwan Advanced Nanotech Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Taiwan Advanced Nanotech Inc.'s total assets of NT$1.34 Billion consist of 71.5% current assets and 28.5% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 21.7% |
| Accounts Receivable | NT$26.67 Million | 1.9% |
| Inventory | NT$252.68 Million | 18.4% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$1.33 Million | 0.1% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Taiwan Advanced Nanotech Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Taiwan Advanced Nanotech Inc.'s current assets represent 71.5% of total assets in 2024, an increase from 0.0% in 2019.
- Cash Position: Cash and equivalents constituted 21.7% of total assets in 2024, down from 41.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 18.4% of total assets.
Taiwan Advanced Nanotech Inc. Competitors by Total Assets
Key competitors of Taiwan Advanced Nanotech Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Taiwan Advanced Nanotech Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Taiwan Advanced Nanotech Inc. generates 0.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Taiwan Advanced Nanotech Inc. is currently not profitable relative to its asset base.
Taiwan Advanced Nanotech Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.69 | 4.38 | 4.30 |
| Quick Ratio | 2.82 | 3.27 | 3.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$725.26 Million | NT$ 852.66 Million | NT$ 1.27 Billion |
Taiwan Advanced Nanotech Inc. - Advanced Valuation Insights
This section examines the relationship between Taiwan Advanced Nanotech Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.48 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -23.2% |
| Total Assets | NT$1.38 Billion |
| Market Capitalization | $8.90 Million USD |
Valuation Analysis
Below Book Valuation: The market values Taiwan Advanced Nanotech Inc.'s assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Taiwan Advanced Nanotech Inc.'s assets decreased by 23.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Taiwan Advanced Nanotech Inc. (2019–2024)
The table below shows the annual total assets of Taiwan Advanced Nanotech Inc. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.38 Billion | -23.17% |
| 2023-12-31 | NT$1.79 Billion | -23.15% |
| 2022-12-31 | NT$2.33 Billion | +5.98% |
| 2021-12-31 | NT$2.20 Billion | +16.77% |
| 2020-12-31 | NT$1.88 Billion | +701.80% |
| 2019-12-31 | NT$234.86 Million | -- |